NeuroDerm's Unattributed Round

NeuroDerm raised a round of funding on August 21, 2014. Investors include The Elias Group.

NeuroDerm is a clinical-stage pharmaceutical company developing central nervous system (CNS) product candidates that are designed to overcome major deficiencies of current treatments and achieve enhan…

Articles about NeuroDerm's Unattributed Round: